IBDEI0NL ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10620,1,3,0)
 ;;=3^Mild Neurocog D/O d/t HUNTINGTON'S DISEASE
 ;;^UTILITY(U,$J,358.3,10620,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,10620,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,10621,0)
 ;;=G31.83^^42^472^24
 ;;^UTILITY(U,$J,358.3,10621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10621,1,3,0)
 ;;=3^Lewy Body Disease
 ;;^UTILITY(U,$J,358.3,10621,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,10621,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,10622,0)
 ;;=F02.81^^42^472^53
 ;;^UTILITY(U,$J,358.3,10622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10622,1,3,0)
 ;;=3^Major Neurocog D/O w/ Poss LEWY BODIES w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10622,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,10622,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,10623,0)
 ;;=F02.80^^42^472^54
 ;;^UTILITY(U,$J,358.3,10623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10623,1,3,0)
 ;;=3^Major Neurocog D/O w/ Poss LEWY BODIES w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10623,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,10623,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,10624,0)
 ;;=F02.81^^42^472^55
 ;;^UTILITY(U,$J,358.3,10624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10624,1,3,0)
 ;;=3^Major Neurocog D/O w/ Prob LEWY BODIES w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10624,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,10624,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,10625,0)
 ;;=F02.80^^42^472^56
 ;;^UTILITY(U,$J,358.3,10625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10625,1,3,0)
 ;;=3^Major Neurocog D/O w/ Prob LEWY BODIES w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10625,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,10625,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,10626,0)
 ;;=G31.84^^42^472^67
 ;;^UTILITY(U,$J,358.3,10626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10626,1,3,0)
 ;;=3^Mild Neurocog D/O w/ LEWY BODIES
 ;;^UTILITY(U,$J,358.3,10626,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,10626,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,10627,0)
 ;;=F02.81^^42^472^31
 ;;^UTILITY(U,$J,358.3,10627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10627,1,3,0)
 ;;=3^Major Neurocog D/O d/t MULTIPLE ETIOLOGIES w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10627,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,10627,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,10628,0)
 ;;=F02.80^^42^472^32
 ;;^UTILITY(U,$J,358.3,10628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10628,1,3,0)
 ;;=3^Major Neurocog D/O d/t MULTIPLE ETIOLOGIES w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10628,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,10628,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,10629,0)
 ;;=G31.84^^42^472^62
 ;;^UTILITY(U,$J,358.3,10629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10629,1,3,0)
 ;;=3^Mild Neurocog D/O d/t MULTIPLE ETIOLOGIES
 ;;^UTILITY(U,$J,358.3,10629,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,10629,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,10630,0)
 ;;=G90.3^^42^472^68
 ;;^UTILITY(U,$J,358.3,10630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10630,1,3,0)
 ;;=3^Multi-System Degeneration of Autonomic Nervous System
 ;;^UTILITY(U,$J,358.3,10630,1,4,0)
 ;;=4^G90.3
 ;;^UTILITY(U,$J,358.3,10630,2)
 ;;=^5004162
 ;;^UTILITY(U,$J,358.3,10631,0)
 ;;=F02.81^^42^472^39
 ;;^UTILITY(U,$J,358.3,10631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10631,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss PARKINSON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10631,1,4,0)
 ;;=4^F02.81
